Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
On 30 September 2016, Pharmaceutical Company Boehringer Ingelheim announced plans to cut up to 9, 000 jobs in Germany by 2021/2022. Mainly affected will be the company's headquarter at Ingelheim as well as its sites in Dortmund and Biberach. According to the spokesperson of Boehringer Ingelheim, the company wants to relocate the production of pharmaceutical products, which are easier to produce in other countries, in order to save costs.
According to sources, job cuts will be implemented as socially acceptable as possible and direct dismissals will be avoided. The company plans to reduce their staff through termination of temporary contracts as well as temporary agency workers and partial retirement. At the moment, about 20% of staff at the headquarter in Ingelheim are employed with a fixed-term contract.
Boehringer Ingelheim employs 3,800 staff in the pharmaceutical production in Germany and in total 47,500 people worldwide. For the latest restructuring see (Boehringer Ingelheim, 2014).
Eurofound (2016), Boehringer Ingelheim, Internal restructuring in Germany, factsheet number 88763, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/88763.